A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Osteoarthritis of the Knee.
Phase of Trial: Phase II
Latest Information Update: 31 Aug 2017
At a glance
- Drugs Lacosamide (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Schwarz Pharma AG; UCB
- 29 Sep 2009 UCB added as trial affiliate and sponsor, actual patient number changed from 193 to 194 as reported by ClinicalTrials.gov.
- 30 Jun 2009 Actual patient number (193) added as reported by ClinicalTrials.gov.
- 30 Jun 2009 Planned end date changed from 1 Nov 2007 to 1 Jan 2008 as reported by ClinicalTrials.gov.